A B S T R A C T The present studies were designed to examine the consequences of chronic mild elevations of endogenous parathyroid hormone (PTH) in vivo on the PTH receptor-adenylate cyclase system of canine kidney cortex. Hyperparathyroidism was induced in normal dogs by feeding a diet low in calcium, high in phosphorus to the animals for a period of 6-9 wk. This maneuver resulted in a two to threefold increase in the plasma levels of carboxy-terminal immunoreactive PTH. This degree of hyperparathyroidism is similar to that seen in patients with hyperparathyroidism and normal renal function. After 6-9 wk on the diet the animals were killed and basolateral renal cortical membranes prepared for the study of the PTH receptor-adenylate cyclase system in vitro. The dietary hyperparathyroidism resulted in desensitization of the PTH-responsive adenylate cyclase (Vmax 3,648±654 pmol cyclic (c)AMP/mg protein per 30 min in hyperparathyroid animals vs. 5,303±348 in normal controls). The Ka.t (concentration of PTH required for half-maximal enzyme activation) was unchanged. However, PTH receptor binding '251[Nle , Nle'8, Tyr34] bPTH (1-34) NH2 as radioligand) was not different in the two groups of animals. Thus, dietary hyperparathyroidism resulted in an uncoupling of the PTH receptor-adenylate cyclase system. This defect was not corrected
INTRODUCTION
Constant exposure of the parathyroid hormone (PTH)' receptor-adenylate cyclase system of the renal cortex to high levels of PTH results in a decreased response to further stimulation of the enzyme with the same hormone. This general phenomenon, known as desensitization, has been demonstrated both in vivo and in vitro not only for PTH but also for a variety of other hormone-and neurotransmitter-sensitive adenylate cyclase systems (1) (2) (3) (4) (5) (6) (7) (8) (9) . This phenomenon may be an important mechanism for the regulation of the effects of these hormones and/or neurotransmitters (10) . The precise alterations that can lead to desensitization ' Abbreviations used in this paper: bPTH, bovine PTH; C, catalytic subunit; G/F, nucleotide regulatory protein; Gpp(NH)p, 5'-guanylyl imidodiphosphate; GTP, guanosine triphosphate; iPTH, immunoreactive PTH; K.C,, concentration of PTH required for half-maximal enzyme activation; '25I[Nle8, Nle '8, Tyr34] , '251-norleucyl8-norleucyl'8-tyrosinyl34; PTH, parathyroid hormone; syn, synthetic.
within the hormone-receptor-adenylate cyclase system are ill defined and vary according to the tissue studied and the experimental conditions (10, 11) . Adenylate cyclase activation is dependent on the interaction of at least three classes of components: the hormone-receptor complex, the nucleotide regulatory protein (G/ F), and the catalytic subunit (C). Accordingly, the desensitization process can potentially involve different regulatory steps in the adenylate cyclase complex.
Previous studies have examined the mechanisms of desensitization of the PTH-responsive adenylate cyclase system of kidney cortex in different experimental models in vivo. Mahoney and Nissenson (12) used the constant infusion of bovine parathyroid extract to parathyroidectomized dogs for a period of 20 h and demonstrated that desensitization of PTH-responsive adenylate cyclase in vitro was due, at least in part, to apparent receptor loss. Similar findings were obtained by Forte et al. (13) in renal cortical membranes from chickens rendered hyperparathyroid for up to 3 wk by dietary calcium and/or vitamin D restriction. While high concentrations of PTH were achieved in plasma in the studies in dogs, no direct measurements of plasma PTH were obtained in the studies in chickens. However, it is likely that the degree of hyperparathyroidism was severe due to persistent marked hypocalcemia. The present studies were designed to examine the PTH-receptor-adenylate cyclase system of canine kidney cortex during a mild chronic hyperparathyroid state, similar in degree to that seen in human parathyroid disease states.
METHODS
Studies were performed in 14 adult normal mongrel dogs. The experimental group (seven dogs) received a low calcium, normal phosphorus diet (0.01% g/dry wt of Ca, 0.8-1% g/ dry wt of Pi) supplemented with 6 g of inorganic phosphorus for a period of 6-9 wk. The control group (seven dogs) received normal dog chow (0.8-1% g/dry wt of Ca, 0.8-1% g/dry wt of Pi). Blood for determination of the levels of immunoreactive (i)PTH, total and ionized calcium, phosphorus, magnesium, blood urea nitrogen, and creatinine were obtained weekly in the experimental animals throughout the study. After a period of [6] [7] [8] [9] wk, under general anesthesia (pentobarbital 30 mg/kg of body wt i.v.) and heparin (5,000 IU, i.v.), the kidneys were removed, perfused with ice-cold saline to remove residual blood and basolateral membranes were prepared from the cortex by differential centrifugation and sucrose gradient ultracentrifugation as previously described (14, 15 (18) . Synthetic (syn) bPTH was added at the indicated concentrations. The binding of the radioligand to kidney membranes is specific and saturable and correlates with biologic activity in the adenylate cyclase assay (14, 19, 20) . The incubations were performed at 16°C for 60 min. Free radioligand was separated from membrane-bound radioligand by the microcentrifuge method. Radioactivity in the tips of the microcentrifuge tubes containing membrane-bound hormone was counted in a gamma counter (model 4600, Micromedic Systems Div., Rohm & Haas Co., Horsham, PA). Under the experimental conditions used, nonspecific binding (radioactivity remaining in the tips of the microfuge tubes from incubations containing membranes and 10-5 M syn bPTH (1-34) was 5.9±0.6% of the total radioactivity added. The specific binding calculated by subtracting the nonspecific binding from the total binding was 17.8±1% of the total radioactivity added in the absence of exogenous guanyl nucleotides.
To were equilibrated with 5 ml of a solution containing 0.1% trifluoroacetic acid (vol/vol) and 80% (vol/vol) acetonitrile and washed with 5 ml of 0.1% (vol/vol) trifluoroacetic solution. Then 2 ml of plasma was applied followed by 20 ml of 0.1% trifluoroacetic acid solution. Finally, the cartridges were eluted with 3 ml of the solution containing 80% acetonitrile and 0.1% trifluoroacetic acid. This eluate was collected lyophylized and reconstituted with 1 ml of PTH assay buffer and assayed for iPTH. Preliminary studies with plasma containing high levels of canine PTH showed good agreement between the results obtained with extracted and unextracted plasma.
RESULTS
As a result of the low calcium, high phosphorus diet, iPTH values rose from control values of 46±12 gleq/ ml to 80±17 ,uleq/ml after 4-5 wk, to 107±19 ,uleq/ ml at the completion of the study as shown in Fig. 1 . The levels of iPTH in the control period were not different from those of normal control dogs (45±11 i,leq/ml, range ;leq/ml). The values for ionized calcium, phosphorus, and creatinine in the dogs fed low Ca diet are shown in Table I . There was an increase in ionized calcium after 4-5 wk of the diet, which was not maintained at 8-9 wk. Plasma phosphorus de200r WEEKS ON DIET FIGURE 1 Changes in serum iPTH in seven dogs before, during, and at the completion of treatment with a low calcium, high phosphorus diet. The dashed line represents the detection limit of the assay. The numbers in circles represent individual animals. The mean values are 46±12 gleq/ml in the control period, 80±17 uleq/ml after 4-5 wk (P < 0.05), and 107±19 jleq/ml at the end of the study period (P < 0.01).
creased throughout the period of the experimental diet, consistent with the elevation in plasma iPTH. Plasma creatinine values did not change significantly. The dogs were healthy at the completion of the diet as judged for their weights and physical activity.
Adenylate cyclase activity. The data of basal and syn bPTH (1-34)-stimulated adenylate cyclase activity in renal cortical membranes from experimental and control animals are shown in Table II . Basal enzyme activity was slightly but not significantly reduced in the membranes of the hyperparathyroid dogs (352±42 pmol cAMP/mg protein per 30 min vs. 506±68 in control animals, NS). PTH-stimulated enzyme activity was significantly reduced in the experimental animals. As shown in Fig. 2 , net PTH-stimulated enzyme activity was significantly decreased (P < 0.05) in the membranes of the hyperparathyroid animals (Vmax 3,648±654 pmol cAMP/mg protein 30 (Fig. 4) (Table  III) . The concentration of syn bPTH (1-34) required to demonstrate half-maximal binding of radioligand was identical in both groups.
Effects of exogenous guanyl nucleotides on adenylate cyclase activity. Based on the known effects of guanyl nucleotides in the regulation of the hormonereceptor-adenylate cyclase interactions, additional experiments were performed in the presence of the naturally occurring nucleotide GTP or its nonhydrolyzable analogue Gpp(NH)p.
As shown in Fig. 5 , PTH-stimulated adenylate cyclase activity in the presence of Gpp(NH)p (10' M) remained markedly reduced in the membranes from the hyperparathyroid animals. Maximal enzyme activity was 6,453±896 pmol cAMP/mg protein per 30 min in the hyperparathyroid group vs. 9,080±577 pmol cAMP/mg protein per 30 min in controls (P < 0.05). The concentration of PTH required for half-maximal enzyme activation was similar in both groups. Similar results were obtained with GTP (10' Effects of NaF on adenylate cyclase activity. In view of the results obtained with guanylnucleotides, it was of interest to examine the NaF-stimulated enzyme activities as an additional probe for the interaction of G/F and the catalytic moiety of the enzyme. Fig. 8 shows the adenylate cyclase activity in the presence of 10 mM NaF. It is clear that the membranes from the hyperparathyroid dogs have a decreased response to NaF compared with control animals (8,285±607 pmol cAMP/mg protein per 30 system of kidney cortex, as reflected in a diminished response to in vitro stimulation of the enzyme by syn bPTH (1-34) when compared with membranes of control animals. The affinity of the enzyme for PTH was not changed. This decrease in PTH-stimulated enzyme activity correlated with the increased plasma levels of iPTH achieved by the experimental diet (Fig. 3 ). Animals 6 and 7, with the lowest final levels of plasma iPTH, showed no reduction in PTH-stimulated adenylate cyclase activity while animal 1, with the highest level of plasma iPTH, showed the greatest reduction in enzyme activity. The correlation of final plasma iPTH values with in vitro PTH-stimulated adenylate cyclase activities is not apparent, however, if the fold rise in plasma iPTH is considered. Thus, animals 3 and 4, with the highest fold rise in iPTH had PTH-stimulated adenylate cyclase activities in vitro within or slightly below the range found in the control animals. Further studies will be required to clarify the relationship of in vitro PTH-stimulated adenylate cyclase activity to circulating levels of biologically active PTH.
Since the degree of desensitization of PTH-stimulated adenylate cyclase activity was greatest in animals 1 and 2, it is necessary to consider whether these two animals were anomalous in some way at the start of the study. However, they were normal healthy-looking Renal PTH Receptor-Cyclase in Dietary-induced Hyperparathyroidism in these animals as due to an effect of the dietaryinduced hyperparathyroidism.
The desensitization of the adenylate cyclase was not accompanied by down-regulation of PTH receptors, which showed normal binding capacity and affinity in each animal. These observations indicate that the de-SYN-b-PTH [M] Gpp (NH)p [Ml Accordingly, further experiments were performed using NaF as an additional probe for the interaction of G/F and the catalytic subunit (C). Enzyme activity in the presence of NaF was significantly reduced in the membranes from the hyperparathyroid animals. The magnitude of this reduction was similar in degree to the reduction in PTH-stimulated enzyme activity in the presence or absence of guanine nucleotides. Thus, as assessed with NaF, the interaction of G/F with C appears to be impaired in the membranes from the hyperparathyroid animals. The explanation for the different results obtained with nonhormonal stimulators of adenylate cyclase (GppNHp and NaF) is not clear. It is possible that this difference is related to the markedly greater enzyme activity attained with NaF compared with Gpp(NH)p. Alternatively, since there I is evidence that the effects of NaF and GppNHp on the regulatory protein have some differences, for example, heat stability, trypsin sensitivity, and other indirect criteria (27, 28) (hence the designation G/F), it is possible that the nature of the defective G/F to C interaction in the membranes from the hyperparathyroid animals is more closely related to the site (or nature) of the action of NaF than to Gpp(NH)p.
Since there is increasing evidence for the existence of other poorly characterized factors (cytoskeletal or intrinsic to the membrane) that can play a role in the regulation of the interactions between the components of adenylate cyclase system (29) (30) (31) (32) (33) , it is possible that such factors may play a role in the mechanisms of the altered receptor-cyclase coupling of the present studies.
The results of the present studies differ from previous investigations by our laboratory (18) and others (12, 13) on PTH desensitization in vitro or in vivo.
Thus, we have shown that in the isolated perfused dog kidney, short-term constant exposure to syn bPTH results in desensitization, which can be attributed to persistent receptor occupancy (18) . Studies of shortterm infusions of bovine parathyroid gland extract in the dog in vivo by Mahoney and Nissenson (12) (34) (35) (36) , it is possible that such episodic exposure to PTH may influence the PTH receptor-adenylate cyclase system in a manner different from constant exposure to the hormone. Further studies will be required to evaluate this possibility.
In summary, the induction of dietary hyperparathyroidism in adult mongrel dogs results in a variable degree of desensitization of the PTH-responsive adenylate cyclase system of kidney cortex to further stimulation with syn bPTH (1-34) without any alteration in PTH receptor binding. This defect, demonstrable by NaF activation, not corrected by guanyl nucleotides, appears to be due to a postreceptor event leading to abnormal receptor-cyclase coupling. The precise nature of the factor(s) other than guanyl nucleotides that may regulate receptor-adenylate cyclase interactions will require further investigation.
